Skip to main navigation Skip to search Skip to main content

Receptors involved in microenvironment-driven molecular evolution of cancer cells

  • Rinat Eshel
  • , Eran Neumark
  • , Orit Sagi-Assif
  • , Isaac P. Witz*
  • *Corresponding author for this work
  • Tel Aviv University

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Cells, including cancer cells, communicate with their microenvironment via various types of membrane receptors. An important down-stream effect of such interactions is a change in the molecular phenotype of the cells. The microenvironment-driven molecular evolution of cancer cells may induce either growth arrest or death of the cells or alternatively, boost their malignancy phenotype. In this paper we summarize studies from our own laboratory on interactions of cancer cells with microenvironmental ligands via two types of receptors that are not commonly associated with tumour progression i.e. the receptor for the Fc portion of IgG, and Ly-6 proteins of mouse and human origin. We also review information on interactions of tumour-associated chemokines and chemokine receptors with the corresponding microenvironmental factors. We demonstrate how these interactions may drive the molecular evolution of tumour cells and discuss the possible impact of this evolution on tumour progression.

Original languageEnglish
Pages (from-to)139-147
Number of pages9
JournalSeminars in Cancer Biology
Volume12
Issue number2
DOIs
StatePublished - 2002

Funding

Funders
Fainbarg Family Fund
Gabrielle Rich Leukaemia Research Foundation
Israel Cancer Association

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Chemokines
    • Extravasation
    • Ly-6
    • Selectin ligands
    • Tumour microenvironment

    Fingerprint

    Dive into the research topics of 'Receptors involved in microenvironment-driven molecular evolution of cancer cells'. Together they form a unique fingerprint.

    Cite this